Cancer is now the second leading cause of death worldwide, and rates are climbing-especially in younger adults. Breast, ...
(Alliance News) - GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemotherapy, to include all adult patients with primary advanced or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback